-
DiscoveryBuilding collaborations to fight a pandemic
Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.
Discovery -
Access to HealthcareEnsuring medicine supply to patients during COVID-19
Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.
Access to Healthcare -
DiscoveryCollaborating to explore new gene regulation therapies
Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.
Discovery -
Breaking a vicious cycle of inflammation
Novartis researchers aim to quash inflammation to treat chronic disease.
-
DiscoveryHelping clinical trial patients during a lockdown
Yan Zhao talks about how her team in China responded to an emerging public health crisis.
Discovery -
Access to HealthcareCancer didn’t stop for COVID-19
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
Access to Healthcare -
Access to HealthcareStreamlining systems to respond to COVID-19
Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
Access to Healthcare -
DiscoveryMoving from speculation to science during a pandemic
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
Discovery -
DiscoveryIt takes an R&D village to fight a pandemic
Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
Discovery -
From Our LabsA visual tour of scientific strategies for combating coronavirus
Researchers around the world are collaborating to provide solutions to immediate and future challenges.
From Our Labs -
People and CultureGoing the extra mile to keep clinical trials on track during the COVID-19 pandemic
A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
People and Culture -
DiscoveryCOVID-19: Answering your top questions
Novartis CEO Vas Narasimhan answers questions about COVID-19.
Discovery